[Federal Register Volume 84, Number 149 (Friday, August 2, 2019)]
[Notices]
[Page 37877]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-16534]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Board of Scientific Counselors, National Center for Injury 
Prevention and Control, (BSC, NCIPC)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of closed meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
announces the following meeting for the Board of Scientific Counselors, 
National Center for Injury Prevention and Control, (BSC, NCIPC).

DATES: The meeting will be held on August 27, 2019 09:00 a.m. to 05:00 
p.m., EDT (CLOSED).

ADDRESSES: In-Person and Teleconference; 4770 Buford Highway NE, 
Atlanta, GA 30341.

FOR FURTHER INFORMATION CONTACT: Gwendolyn H. Cattledge, Ph.D., 
M.S.E.H., Deputy Associate Director for Science, NCIPC, CDC, 4770 
Buford Highway NE, Mailstop F-63, Atlanta, GA 30341, Telephone (770) 
488-3953, Email address: [email protected].

SUPPLEMENTARY INFORMATION: The meeting will be closed to the public in 
accordance with provisions set forth in Section 552b(c)(4) and (6), 
Title 5 U.S.C., and the Determination of the Chief Operating Officer, 
Office of the Chief Operating Officer, CDC, pursuant to Public Law 92-
463.
    Purpose: The Board will: (1) Conduct, encourage, cooperate with, 
and assist other appropriate public health authorities, scientific 
institutions, and scientists in the conduct of research, 
investigations, experiments, demonstrations, and studies relating to 
the causes, diagnosis, treatment, control, and prevention of physical 
and mental diseases, and other impairments; (2) assist States and their 
political subdivisions in preventing and suppressing communicable and 
non-communicable diseases and other preventable conditions and in 
promoting health and well-being; and (3) conduct and assist in research 
and control activities related to injury. The BSC, NCIPC makes 
recommendations regarding policies, strategies, objectives, and 
priorities; and reviews progress toward injury prevention goals and 
provides evidence in injury prevention-related research and programs. 
The Board also provides advice on the appropriate balance of intramural 
and extramural research, and the structure, progress and performance of 
intramural programs. The Board is designed to provide guidance on 
extramural scientific program matters, including the: (1) Review of 
extramural research concepts for funding opportunity announcements; (2) 
conduct of Secondary Peer Review of extramural research grants, 
cooperative agreements, and contracts applications received in response 
to funding opportunity announcements as they relate to the Center's 
programmatic balance and mission; (3) submission of secondary review 
recommendations to the Center Director of applications to be considered 
for funding support; (4) review of research portfolios, and (5) review 
of program proposals.
    Matters To Be Considered: The agenda will include discussions on 
Secondary Peer Review of extramural research grant and cooperative 
agreement applications received in response to five (5) Notice of 
Funding Opportunities (NOFO): RFA-CE19-002--Research Grants to Identify 
Effective Strategies for Opioid Overdose Prevention; RFA-CE19-003--
Evaluation of Return to School Programs for Traumatic Brain Injury; 
RFA-CE19-005--Research Grants for Preventing Violence and Violence-
Related Injury (R01); RFA-CE19-006--Grants to Support New Investigators 
in Addressing Cross-Cutting Violence Prevention and Opioid Overdose 
Prevention and; funding notices for Small Business Innovation 
Research--PA-18-573-PHS 2018-02 Omnibus Solicitation of the NIH for 
Small Business Innovation Research Grant Applications (Parent SBIR 
[R43/R44] Clinical Trial Required) and/or PA-18-574-PHS 2018-02 Omnibus 
Solicitation of the NIH, CDC, and FDA for Small Business Innovation 
Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not 
Allowed). Agenda items are subject to change as priorities dictate.
    The Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-16534 Filed 8-1-19; 8:45 am]
BILLING CODE 4163-18-P